Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CRAFT Rocket (also known as CRAFT Rocket 31:01) is a medical cannabis flower product imported and distributed in Germany by DEMECAN. The product is cultivated in Canada by Rocket Factory using the cultivar Facetz, which is a hybrid genetic cross of Pavé S1 and Gastro Pop #5 (bred by Compound Genetics). CRAFT Rocket is non-irradiated (unbestrahlt) and features a high tetrahydrocannabinol (THC) content of approximately 31% and a low cannabidiol (CBD) content of less than 1%. Its terpene profile is dominated by beta-myrcene, limonene, linalool, and trans-caryophyllene, giving it a sweet, fruity, and slightly gassy/diesel aroma. It is prescribed for the treatment of conditions such as chronic pain, stress, and depression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CRAFT Rocket.